Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in a patient with graft-versus-host disease

被引：0

作者：

Kuhnowski F. ^{[1
]}

Terriou L. ^{[1
]}

Magro L. ^{[1
]}

Jouet J.-P. ^{[1
]}

Yakoub-Agha I. ^{[1
]}

机构：

[1] Service des Maladies du Sang, UAM Allogreffes de CSH, CHRU, Lille

来源：

Drugs | 2006年 / 66卷 / Suppl 2期

关键词：

Imatinib; Tacrolimus; Chronic Myeloid Leukaemia; Mycophenolate Mofetil; Busulfan;

D O I：

10.2165/00003495-200666002-00009

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用

页码：29 / 31

页数：2

共 5 条

[1]

Baron F., Storb R., Little M.T., Hematopoietic cell transplantation: Five decades of progress, Arch Med Res, 34, pp. 528-544, (2003)

[2]

Basara N., Blau W.I., Kiehl M.G., Et al., Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient, Transplant Proc, 30, pp. 4087-4089, (1998)

[3]

Busca A., Saroglia E.M., Lanino E., Et al., Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation, Bone Marrow Transplant, 25, pp. 1067-1071, (2000)

[4]

Kim J.G., Sohn S.K., Kim D.H., Et al., Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant, Eur J Haematol, 73, pp. 56-61, (2004)

[5]

Bolwell B., Sobecks R., Pohlman B., Et al., A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation, Bone Marrow Transplant, 34, pp. 621-625, (2004)

← 1 →